NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV
Delisted
NBRV was delisted on the 31st of July, 2023.
42 hedge funds and large institutions have $73.3M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
42% less capital invested
Capital invested by funds: $127M → $73.3M (-$53.9M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
42
Holding in Top 10
1
Calls
$492K
Puts
$121K
Top Buyers
| 1 | +$808K | |
| 2 | +$622K | |
| 3 | +$371K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$223K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$189K |
Top Sellers
| 1 | -$6.76M | |
| 2 | -$4.14M | |
| 3 | -$2.81M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.99M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$1.9M |